Lianming Liao1, Wei Chen2, Haichun Lai2, Xuehan Yi2, Desheng Wang3. 1. Department of Laboratory Medicine, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian, China. 2. Department of Otolaryngology, Fujian Medical University Union Hospital, 29# Xinquan Road, Fuzhou, 350001, Fujian, China. 3. Department of Otolaryngology, Fujian Medical University Union Hospital, 29# Xinquan Road, Fuzhou, 350001, Fujian, China. wangds@fjmu.edu.cn.
Abstract
PURPOSE: Immune scores have been used as a prognostic factor for various types of cancer. However, the association between immune scores and the prognosis of laryngeal squamous cell cancer (LSCC) has not yet been investigated. This study aimed to explore the prognostic significance of immune scores and construct a clinical nomogram to predict the survival of patients with LSCC. METHODS: The clinicopathological characteristics and immune scores of 102 patients with LSCC were obtained from TCGA database and a nomogram was developed. C-index and calibration curves were applied to assess the performance of the model. RESULTS: Patients with higher immune scores had significantly better overall survival (OS). The prognostic nomogram presented a good performance in survival prediction. CONCLUSIONS: High immune scores are correlated with improved OS in patients with LSCC. In addition, the nomogram developed for this study may assist clinicians in the prognostic evaluation of patients with LSCC.
PURPOSE: Immune scores have been used as a prognostic factor for various types of cancer. However, the association between immune scores and the prognosis of laryngeal squamous cell cancer (LSCC) has not yet been investigated. This study aimed to explore the prognostic significance of immune scores and construct a clinical nomogram to predict the survival of patients with LSCC. METHODS: The clinicopathological characteristics and immune scores of 102 patients with LSCC were obtained from TCGA database and a nomogram was developed. C-index and calibration curves were applied to assess the performance of the model. RESULTS:Patients with higher immune scores had significantly better overall survival (OS). The prognostic nomogram presented a good performance in survival prediction. CONCLUSIONS: High immune scores are correlated with improved OS in patients with LSCC. In addition, the nomogram developed for this study may assist clinicians in the prognostic evaluation of patients with LSCC.
Authors: Kosuke Yoshihara; Maria Shahmoradgoli; Emmanuel Martínez; Rahulsimham Vegesna; Hoon Kim; Wandaliz Torres-Garcia; Victor Treviño; Hui Shen; Peter W Laird; Douglas A Levine; Scott L Carter; Gad Getz; Katherine Stemke-Hale; Gordon B Mills; Roel G W Verhaak Journal: Nat Commun Date: 2013 Impact factor: 14.919
Authors: Nathan Wong; Shariq S Khwaja; Callie M Baker; Hiram A Gay; Wade L Thorstad; Mackenzie D Daly; James S Lewis; Xiaowei Wang Journal: Cancer Med Date: 2016-04-25 Impact factor: 4.452
Authors: Sangeetha Prabhakaran; Victoria T Rizk; Zhenjun Ma; Chia-Ho Cheng; Anders E Berglund; Dominico Coppola; Farah Khalil; James J Mulé; Hatem H Soliman Journal: Breast Cancer Res Date: 2017-06-19 Impact factor: 6.466
Authors: Georgia Karpathiou; Francois Casteillo; Jean-Baptiste Giroult; Fabien Forest; Pierre Fournel; Alessandra Monaya; Marios Froudarakis; Jean Marc Dumollard; Jean Michel Prades; Michel Peoc'h Journal: Oncotarget Date: 2017-03-21